Inhibition of cardiac Na+, K+-ATPase activity by dynorphin-A and ethylketocyclazocine
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (4), 461-468
- https://doi.org/10.1016/0024-3205(88)90085-9
Abstract
No abstract availableFunding Information
- Kementerian Pendidikan dan Kebudayaan
This publication has 21 references indexed in Scilit:
- The effect of opioids and of naloxone on Na+,K+-adenosine triphosphatase activity in frog spinal cord membrane fractionsNeuroscience Letters, 1985
- Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atriaEuropean Journal of Pharmacology, 1985
- Presynaptic opioid receptors in the rabbit ear arteryLife Sciences, 1983
- Characterization of opioid peptides in guinea-pig heart and skinLife Sciences, 1983
- Central cardiovascular effects of κ agonists dynorphin-(1–13) and ethylketocyclazocine in the anaesthetized ratEuropean Journal of Pharmacology, 1983
- Cardiovascular Effects of Endogenous Opiate SystemsAnnual Review of Pharmacology and Toxicology, 1983
- Evidence for the presence of enkephalins in the heartLife Sciences, 1983
- Immunohistochemical studies using antibodies to leucine-enkephalin: Initial observations on the nervous system of the ratNeuroscience, 1976
- Purification and characterization ofBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934